Literature DB >> 23057591

Low-salt diet and cyclosporine nephrotoxicity: changes in kidney cell metabolism.

Jelena Klawitter1,2, Jost Klawitter1, Volker Schmitz1,3, Nina Brunner1,3, Amanda Crunk1, Kyler Corby1, Jamie Bendrick-Peart1, Dieter Leibfritz4, Charles L Edelstein2, Joshua M Thurman2, Uwe Christians1.   

Abstract

Cyclosporine (CsA) is a highly effective immunosuppressant used in patients after transplantation; however, its use is limited by nephrotoxicity. Salt depletion is known to enhance CsA-induced nephrotoxicity in the rat, but the underlying molecular mechanisms are not completely understood. The goal of our study was to identify the molecular effects of salt depletion alone and in combination with CsA on the kidney using a proteo-metabolomic strategy. Rats (n = 6) were assigned to four study groups: (1) normal controls, (2) low-salt fed controls, (3) 10 mg/kg/d CsA for 28 days on a normal diet, (4) 10 mg/kg/d CsA for 28 days on low-salt diet. Low-salt diet redirected kidney energy metabolism toward mitochondria as indicated by a higher energy charge than in normal-fed controls. Low-salt diet alone reduced phospho-AKT and phospho-STAT3 levels and changed the expression of ion transporters PDZK1 and CLIC1. CsA induced macro- and microvesicular tubular epithelial vacuolization and reduced energy charge, changes that were more significant in low-salt fed animals, probably because of their more pronounced dependence on mitochondria. Here, CsA increased phospho-JAK2 and phospho-STAT3 levels and reduced the phospho-IKKγ and p65 proteins, thus activating NF-κB signaling. Decreased expression of lactate transport regulator CD147 and phospho-AKT was also observed after CsA exposure in low-salt rats, indicating a decrease in glycolysis. In summary, our study suggests a key role for PDZK1, CD147, JAK/STAT, and AKT signaling in CsA-induced nephrotoxicity and proposes mechanistic explanations on why rats fed a low-salt diet have higher sensitivity to CsA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23057591      PMCID: PMC3831655          DOI: 10.1021/pr300260e

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  71 in total

1.  PDZK1: I. a major scaffolder in brush borders of proximal tubular cells.

Authors:  Serge M Gisler; Sandra Pribanic; Desa Bacic; Patrik Forrer; Andrea Gantenbein; Luc A Sabourin; Akira Tsuji; Zhuo-Shen Zhao; Edward Manser; Jürg Biber; Heini Murer
Journal:  Kidney Int       Date:  2003-11       Impact factor: 10.612

Review 2.  Transport of organic anions across the basolateral membrane of proximal tubule cells.

Authors:  B C Burckhardt; G Burckhardt
Journal:  Rev Physiol Biochem Pharmacol       Date:  2003-01-30       Impact factor: 5.545

3.  Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity.

Authors:  Fuad S Shihab; William M Bennett; Hong Yi; Seung-Ok Choi; Takeshi F Andoh
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

4.  Cyclosporin A-induced changes in endogenous metabolites in rat urine: a metabonomic investigation using high field 1H NMR spectroscopy, HPLC-TOF/MS and chemometrics.

Authors:  E M Lenz; J Bright; R Knight; I D Wilson; H Major
Journal:  J Pharm Biomed Anal       Date:  2004-05-28       Impact factor: 3.935

5.  Targeted disruption of the PDZK1 gene by homologous recombination.

Authors:  Olivier Kocher; Rinku Pal; Mark Roberts; Christine Cirovic; Annalyn Gilchrist
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

6.  Chloride, not sodium, stimulates expression of the gamma subunit of Na/K-ATPase and activates JNK in response to hypertonicity in mouse IMCD3 cells.

Authors:  Juan M Capasso; Christopher J Rivard; Laura M Enomoto; Tomas Berl
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-13       Impact factor: 11.205

7.  Long-term treatment with cyclosporine decreases aquaporins and urea transporters in the rat kidney.

Authors:  Sun-Woo Lim; Can Li; Bo-Kyung Sun; Ki-Hwan Han; Wan-Young Kim; Yoon-Wha Oh; Jong-Un Lee; Peter F Kador; Mark A Knepper; Jeff M Sands; Jin Kim; Chul-Woo Yang
Journal:  Am J Physiol Renal Physiol       Date:  2004-02-10

8.  Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats.

Authors:  S M Gardiner; J E March; P A Kemp; B Fallgren; T Bennett
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

9.  Organ-specific response to inhibition of mitochondrial metabolism by cyclosporine in the rat.

Authors:  Natalie Serkova; Jost Klawitter; Claus U Niemann
Journal:  Transpl Int       Date:  2003-06-24       Impact factor: 3.782

10.  Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN.

Authors:  Yi Tang; Prabakaran Kesavan; Marian T Nakada; Li Yan
Journal:  Mol Cancer Res       Date:  2004-02       Impact factor: 5.852

View more
  8 in total

Review 1.  Function of CD147 in atherosclerosis and atherothrombosis.

Authors:  Cuiping Wang; Rong Jin; Xiaolei Zhu; Jinchuan Yan; Guohong Li
Journal:  J Cardiovasc Transl Res       Date:  2015-01-21       Impact factor: 4.132

Review 2.  The Many Faces of Calcineurin Inhibitor Toxicity-What the FK?

Authors:  Samira S Farouk; Joshua L Rein
Journal:  Adv Chronic Kidney Dis       Date:  2020-01       Impact factor: 3.620

3.  Pharmacokinetic and nephroprotective benefits of using Schisandra chinensis extracts in a cyclosporine A-based immune-suppressive regime.

Authors:  Qiao Lai; Jiabao Wei; Mohammed Mahmoodurrahman; Chenxue Zhang; Shijian Quan; Tongming Li; Yang Yu
Journal:  Drug Des Devel Ther       Date:  2015-08-28       Impact factor: 4.162

Review 4.  The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature.

Authors:  Lijuan Xiong; Carl K Edwards; Lijun Zhou
Journal:  Int J Mol Sci       Date:  2014-09-29       Impact factor: 5.923

Review 5.  Identification of Novel Biomarkers for Predicting Kidney Injury Due to Drugs Using "Omic" Strategies.

Authors:  Linda Awdishu; Amandla Atilano-Roque; Stacey Tuey; Melanie S Joy
Journal:  Pharmgenomics Pers Med       Date:  2020-12-02

Review 6.  Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates.

Authors:  Sajad Fakhri; Zeinab Nouri; Seyed Zachariah Moradi; Esra Küpeli Akkol; Sana Piri; Eduardo Sobarzo-Sánchez; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  Molecules       Date:  2021-05-14       Impact factor: 4.411

7.  Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat.

Authors:  Rahul Bohra; Wenzel Schöning; Jelena Klawitter; Nina Brunner; Volker Schmitz; Touraj Shokati; Ryan Lawrence; Maria Fernanda Arbelaez; Björn Schniedewind; Uwe Christians; Jost Klawitter
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

8.  Mycophenolate mofetil enhances the negative effects of sirolimus and tacrolimus on rat kidney cell metabolism.

Authors:  Jelena Klawitter; Jost Klawitter; Volker Schmitz; Touraj Shokati; Ekaterina Epshtein; Joshua M Thurman; Uwe Christians
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.